(Q45965455)

English

Biological characteristics and epidermal growth factor receptor tyrosine kinase inhibitors efficacy of EGFR mutation and its subtypes in lung adenocarcinoma.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

Biological characteristics and epidermal growth factor receptor tyrosine kinase inhibitors efficacy of EGFR mutation and its subtypes in lung adenocarcinoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

1 reference

based on heuristic

inferred from title

author name string

Rong-Li Lu

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

Cheng-Ping Hu

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

Hua-Ping Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

Yuan-Yuan Li

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

Qi-Hua Gu

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

Lielin Wu

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

publication date

3 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

Pathology Oncology Research

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

20

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

445-451

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

https://scigraph.springernature.com/pub.10.1007/s12253-013-9715-0

0 references

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Environmental and dietary factors and lung cancer risk among Chinese women: a case-control study in southeast China.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Trans, trans-2,4-decadienal, a product found in cooking oil fumes, induces cell proliferation and cytokine production due to reactive oxygen species in human bronchial epithelial cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Screening for epidermal growth factor receptor mutations in lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Comparison of gefitinib versus erlotinib in patients with nonsmall cell lung cancer who failed previous chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-013-9715-0

21 January 2018

[Detection of epidermal growth factor receptor mutations in non-small-cell lung carcinoma by direct sequencing and correlations with clinicopathological characteristics and sample types].

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cooking oil fumes and risk of lung cancer in women in rural Gansu, China

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer].

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chinese food cooking and lung cancer in women nonsmokers

1 reference

https://pubmed.ncbi.nlm.nih.gov/24297623

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12253-013-9715-0

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

Dimensions Publication ID

0 references

release_gyz7qmwmn5hsbl6dkxnbarbrva

1 reference

https://api.fatcat.wiki/v0/release/gyz7qmwmn5hsbl6dkxnbarbrva

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/24297623

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45965455&oldid=1837281894"